March 2005
DTC's reputation as a bully may be largely overstated. There's little evidence that sales of specific drugs increase.
If clinical mistakes were as common as clerical ones, nobody would leave a hospital alive. Something needs to be done, and done soon.
There aren't enough geriatricians to go around, but judicious use of these specialists can still do a lot for an aged population.
A significant number of consultants, insurers, politicians, and, oh yes, the companies that purchase health care are increasing their interest.
The company's Mid-Atlantic States Region has seen impressive savings since launching one of its disease management programs.
A Conversation with John Sory
As a vice president of Pfizer Health Solutions, a major DM company, John Sory knows how difficult it is to bring systematic care to the chronically ill.
The $60 billion to $108 billion that could be saved through tort reform would help 2.4 million to 4.3 million uninsured get coverage, the government claims.
TOMORROW'S MEDICINE
A single strand of nucleic acid may hold the key to treating the leading cause of severe vision loss and blindness resulting from age-related macular degeneration.
Compensation Monitor
Editor’s Memo
Employer Update
A consortium of employers is paying the pharmacy benefit manager a new administration fee but taking all rebates and discounts.
The Formulary Files
Managed Care Outlook
Viewpoint
Standardizing health plan administrative processes and eliminating duplication of effort would go a long way toward strengthening the doctor-insurer relationship.
Follow us
Today's popular content
- How Doctors Are Paid Now, And Why It Has to Change
- Through the Looking Glass
- Occupy the OR
- What the Primary Care Physician Shortage Means for Health Plans
- Specialty Pharmacy Management Will Become More Intense
- Large employers agree on rewarding healthy behavior
- It's To Plans' Benefit To Spell Out Authority
- Health Plans Can Learn From VHA Turnaround
- Transparency Called Key To Uniting Cost Control, Quality Improvement
- Insurers skeptical of usefulness of companion diagnostics
Recent blog posts
- Health Care Industry’s Moment of Truth Is Approaching
- Through the Looking Glass
- Physician Practices Hiring Care Coordinators
- Who Will Pay for High-Cost Biologics?
- Health exchanges stumble to the starting line
- It's Elementary
- Yet Another Warning About Antibiotic Overprescribing
- Let the EMR Backlash Begin
- Not a Third World Experience
- UK: Health Care Policy Mayhem…and a Very Public Scandal
